AMSF vs EMD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMSF's Piotroski F-Score of 3/9 indicates weak financial health, with no Altman Z-Score available to confirm solvency. Despite a defensive Graham Number of $27.28 and an intrinsic value estimate of $17.29, the stock trades at $32.85—significantly above both benchmarks. This suggests overvaluation, especially given deteriorating earnings growth (-19.2% YoY) and a recent streak of missed earnings (0/4 beats in last 4 quarters). The bearish technical trend and negative insider activity further undermine confidence.
EMD exhibits strong value characteristics with a stable Piotroski F-Score of 6/9 and significant undervaluation relative to its Graham Number ($20.97) and Intrinsic Value ($51.33). The fund is trading at a low P/E of 6.17 and a Price/Book of 0.96, suggesting a deep discount to its underlying assets. While technical trends and insider sentiment are currently bearish, the combination of a 10.61% dividend yield and robust earnings growth (48.20%) provides a strong fundamental floor.
Compare Another Pair
Related Comparisons
AMSF vs EMD: Head-to-Head Comparison
This page compares AMERISAFE, Inc. (AMSF) and Western Asset Emerging Markets Debt Fund Inc. (EMD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.